Source:http://linkedlifedata.com/resource/pubmed/id/15000148
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1-2
|
pubmed:dateCreated |
2004-3-5
|
pubmed:abstractText |
Genetic inactivation of key components of the Wnt signal transduction system is a frequent event in colorectal cancer. These genetic mutations lead to stabilization of beta-catenin, a cytoplasmic-nuclear shuttling protein with a potent transcription activation domain. Stabilization and subsequent nuclear localization of beta-catenin produces aberrant, Wnt-independent signals to target genes, an activity tightly linked to the genesis of colon cancers. In the nucleus, the transcription factor family of LEF/TCF proteins transmits Wnt signals by binding to beta-catenin and recruiting it to target genes for activation. Such activities are carried out by full-length LEF/TCFs that are thought to be mostly interchangeable and redundant. However, truncated forms of LEF-1 and TCF-1 that do not bind to beta-catenin function as dominant negatives and an alternatively spliced TCF isoform with a unique activation function has recently been discovered. The dominant negative forms block Wnt signals because they occupy Wnt target genes and limit beta-catenin access; the alternatively spliced TCF isoform activates certain Wnt target promoters whereas other TCF isoforms and LEF-1 do not. A study of LEF/TCF expression and activity in normal intestine and colon carcinomas suggests that the relative amounts of LEF/TCF isoforms may change as tumors progress and this may influence the strength and specificity of Wnt signals in the nucleus. While the underlying mechanism for a change in the LEF/TCF isoform expression is not yet known, recent evidence implicates the Wnt signaling pathway itself as a potential modulator.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/DNA-Binding Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/LEF1 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Lymphoid Enhancer-Binding Factor 1,
http://linkedlifedata.com/resource/pubmed/chemical/Protein Isoforms,
http://linkedlifedata.com/resource/pubmed/chemical/T Cell Transcription Factor 1,
http://linkedlifedata.com/resource/pubmed/chemical/TCF7 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Transcription Factors
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0167-7659
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
23
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
41-52
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:15000148-Cell Nucleus,
pubmed-meshheading:15000148-Colorectal Neoplasms,
pubmed-meshheading:15000148-DNA-Binding Proteins,
pubmed-meshheading:15000148-Exons,
pubmed-meshheading:15000148-Genes, Dominant,
pubmed-meshheading:15000148-Humans,
pubmed-meshheading:15000148-Lymphoid Enhancer-Binding Factor 1,
pubmed-meshheading:15000148-Models, Biological,
pubmed-meshheading:15000148-Models, Genetic,
pubmed-meshheading:15000148-Promoter Regions, Genetic,
pubmed-meshheading:15000148-Protein Binding,
pubmed-meshheading:15000148-Protein Isoforms,
pubmed-meshheading:15000148-Protein Structure, Tertiary,
pubmed-meshheading:15000148-Signal Transduction,
pubmed-meshheading:15000148-T Cell Transcription Factor 1,
pubmed-meshheading:15000148-Transcription Factors
|
pubmed:articleTitle |
Lymphoid enhancer factor/T cell factor expression in colorectal cancer.
|
pubmed:affiliation |
Department of Microbiology and Molecular Genetics, College of Medicine, University of California, Irvine, USA. mlwaterm@uci.edu
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Review
|